Abstract
Bicyclic acidic amino acids (+/-)-6 and (+/-)-7, which are conformationally constrained homologues of glutamic acid, were prepared via a strategy based on a 1,3-dipolar cycloaddition. The new amino acids were tested toward ionotropic and metabotropic glutamate receptor subtypes; both of them behaved as antagonists at mGluR1,5 and as agonists at mGluR2. Furthermore, whereas (+/-)-6 was inactive at all ionotropic glutamate receptors, (+/-)-7 displayed a quite potent antagonism at the NMDA receptors. In the in vivo tests on DBA/2 mice, the compounds displayed an anticonvulsant activity. The interesting pharmacological profile of (+/-)-7 qualifies it as a lead of novel neuroprotective agents.
Original language | English |
---|---|
Journal | Journal of Medicinal Chemistry |
Volume | 46 |
Issue number | 14 |
Pages (from-to) | 3102-8 |
ISSN | 0022-2623 |
DOIs | |
Publication status | Published - 3 Jul 2003 |
Keywords
- Amino Acids, Acidic
- Amino Acids, Dicarboxylic
- Animals
- Anticonvulsants
- CHO Cells
- Cerebral Cortex
- Cricetinae
- Crystallography, X-Ray
- Dicarboxylic Acids
- Excitatory Amino Acid Agonists
- Excitatory Amino Acid Antagonists
- Heterocyclic Compounds, 2-Ring
- Isoxazoles
- Male
- Mice
- Mice, Inbred DBA
- Molecular Conformation
- Rats
- Receptors, Metabotropic Glutamate
- Receptors, N-Methyl-D-Aspartate
- Stereoisomerism